Lastly, in more recent times, an increasing interest has been recorded in shifting the research focus towards studies on combination therapies, exploring AR targeting as an adjunct treatment to other therapies, for instance, to treat reperfusion injury or prevent cardiac remodelling post-acute myocardial infarction. Here, AR is linked to myocardial infarction.